Beneficial effect of prostaglandin E1 on hepatic allograft rejection following orthotopic liver transplantation.
Tancharoen
S
S
Victorian Liver Transplant Unit, Austin Hospital, Heidelberg, Australia.
Jones
R M
RM
Angus
P W
PW
Hardy
K J
KJ
D000208:Acute Disease; D000527:Alprostadil / Q000008:administration & dosage / Q000494:pharmacology*; D006084:Graft Rejection / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007262:Infusions, Intravenous; D016031:Liver Transplantation / Q000009:adverse effects* / Q000276:immunology; D008775:Methylprednisolone / Q000008:administration & dosage; D016853:Muromonab-CD3 / Q000008:administration & dosage
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D000527:Alprostadil; D008775:Methylprednisolone